Preeclampsia at delivery is associated with lower serum vitamin D and higher antiangiogenic factors: a case control study

Reprod Biol Endocrinol. 2022 Jan 6;20(1):8. doi: 10.1186/s12958-021-00885-z.

Abstract

Background: Preeclampsia is characterized by decreased trophoblastic angiogenesis leading to abnormal invasion of spiral arteries, shallow implantation and resulting in compromised placentation with poor uteroplacental perfusion. Vitamin D plays an important role in pregnancy influencing implantation, angiogenesis and placental development. The objective of this study was to determine whether there is an association between serum vitamin D levels, and anti-angiogenic factors at the time of delivery and the occurrence of preeclampsia.

Methods: This nested case control study analyzed frozen serum samples at the time of delivery and related clinical data from women with singleton liveborn pregnancies who had participated in studies of the NICHD Stillbirth Collaborative Research Network. Women with a recorded finding of preeclampsia and who had received magnesium sulfate treatment prior to delivery were considered index cases (N = 56). Women without a finding of preeclampsia were controls (N = 341).

Results: Women with preeclampsia had 14.5% lower serum vitamin D levels than women in the control group (16.5 ng/ml vs. 19 ng/ml, p = 0.014) with 64.5% higher sFlt-1 levels (11,600 pg/ml vs. 7050 pg/ml, p < 0.001) and greater than 2 times higher endoglin levels (18.6 ng/ml vs. 8.7 ng/ml, < 0.001). After controlling for gestational age at delivery and maternal BMI, vitamin D levels were 0.88 times lower (P = 0.051), while endoglin levels were 2.5 times higher and sFlt-1 levels were 2.1 times higher than in control pregnancies (P < 0.001).

Conclusions: Women with preeclampsia at time of delivery have higher maternal antiangiogenetic factors and may have lower maternal serum vitamin D levels. These findings may lead to a better understanding of the underlying etiology of preeclampsia as well as possible modifiable treatment options which could include assuring adequate levels of maternal serum vitamin D prior to pregnancy.

Keywords: Antiangiogenetic factors; Endoglin; Preeclampsia; Pregnancy; Vitamin D; sFlt-1.

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / blood*
  • Biomarkers / blood
  • Case-Control Studies
  • Delivery, Obstetric* / statistics & numerical data
  • Endoglin / blood
  • Female
  • Humans
  • Infant, Newborn
  • Pre-Eclampsia / blood*
  • Pre-Eclampsia / epidemiology
  • Pregnancy
  • Pregnancy Outcome / epidemiology
  • Risk Factors
  • United States / epidemiology
  • Vascular Endothelial Growth Factor Receptor-1 / blood
  • Vitamin D / blood*
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / epidemiology
  • Vitamin D Deficiency / etiology
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Biomarkers
  • ENG protein, human
  • Endoglin
  • Vitamin D
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1